Potent and selective α4β2 nACh receptor agonist

Highly selective agonist of α4β2 subtype of neural nicotinic acetylcholine receptors

Selective α7 nicotinic acetylcholine receptor (nAChR) agonist

High affinity α2-adrenoceptor antagonist and selective 5-HT uptake inhibitor

Potent and selective cannabinoid CB2 receptor agonist

Negative control for A-745

Potent CCK1 agonist

Potent and selective α7 nAChR partial agonist

Potent and selective AKT>Akt kinases inhibitor

Novel transient receptor potential type V1 receptor antagonist

Novel α4β2 neuronal nicotinic receptor positive allosteric modulator

Selective H3 antagonist

Cannabinoid agonist; Analgesic

Multidrug Resistance (MDR) Modulator

Novel Bcl-XL antagonist

Nicotinic acetylcholine receptor agonist

Selective nonimidazole H3 receptor inverse agonist

Novel and selective H3 receptor antagonist

Multidrug Resistance (MDR) Modulator

Novel adenosine A2A receptor (A2AR) antagonist

Novel potent and orally active adenosine kinase inhibitor

Novel potassium channel opener, more potent enantiomer

Negative control for A-192621

Selective adenosine kinase (AK) inhibitor

Novel blocker of the activation of the TRPV1 channel by capsaicin, inducing hypothermia involving tail-skin, vasodilation at thermoneutrality, decreasing body temperature

Temperature-Neutral Transient Receptor Potential Vanilloid-1 (TRPV1) Antagonist with Analgesic Efficacy

Fluorogenic A9 Peptide Probe, Interacting with Its Receptor Model HER2-DIVMP

Selective TRPV1 antagonist

Natural IDO1 inhibitor, cytotoxic and antiplasmodial agent

Novel natural anticancer agent, exhibiting potent cytotoxicity against PANC-1 human pancreatic cancer cell line under the normoglycemic condition